Exane Derivatives’s Alcon ALC Stock Holding History

Exane Derivatives’s Portfolio ALC Stock Details ALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-58	Closed	-$98.5K	–	882
2021 Q3	$98.5K	Buy	58 +2	+4%	+$154	0.02%	528
2021 Q2	$40.3K	Hold	56	–	–	0.01%	660
2021 Q1	$52.8K	Buy	+56	New	+$3.96K	0.02%	511
2020 Q4	–	Sell	-1,268	Closed	-$34.8K	–	828
2020 Q3	$34.8K	Buy	1,268 +12	+1%	+$706	0.01%	395
2020 Q2	$160K	Buy	1,256 +1,200	+2,143%	+$67.9K	0.04%	230
2020 Q1	$25.9K	Hold	56	–	–	0.01%	396
2019 Q4	$18.3K	Sell	56 -40	-42%	-$2.29K	﹤0.01%	399
2019 Q3	$10.2K	Buy	+96	New	+$5.76K	﹤0.01%	431

Other funds holding ALC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Exane Derivatives's ALC Position: Q2 2022 in Review

Exane Derivatives increased its Alcon (ALC) stake by 56% in Q2 2022, buying an estimated $115K and bringing the position to 4,429 shares worth $308K. The position accounts for 0.18% of the portfolio, ranked #133.

Exane Derivatives first reported a position in ALC in Q4 2020 and has held it in 6 quarters since. The position peaked at $7.62M in Q2 2021. 611 funds tracked by Wall St. Rank hold ALC as of Q2 2022.

Exane Derivatives held 4,429 shares of Alcon worth $308K as of Q2 2022.
Exane Derivatives bought 1,581 Alcon shares in Q2 2022, an estimated $115K.
Alcon made up 0.18% of Exane Derivatives's portfolio in Q2 2022, its #133 holding.
Exane Derivatives first reported a position in Alcon in Q4 2020 and has held it in 6 quarters since.
Exane Derivatives's Alcon position peaked at $7.62M in Q2 2021.
611 funds tracked by Wall St. Rank held Alcon as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.